These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22317983)

  • 1. Blood levels of pyrazinamide in children at doses administered under the Revised National Tuberculosis Control Program.
    Roy V; Sahni P; Gupta P; Sethi GR; Khanna A
    Indian Pediatr; 2012 Sep; 49(9):721-5. PubMed ID: 22317983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood levels of isoniazid in Indian children with tuberculosis.
    Rangari GM; Roy V; Sethi GR; Mishra TK; Khanna A
    Indian J Tuberc; 2015 Apr; 62(2):80-5. PubMed ID: 26117476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrazinamide blood concentrations in children suffering from tuberculosis: a comparative study at two doses.
    Gupta P; Roy V; Sethi GR; Mishra TK
    Br J Clin Pharmacol; 2008 Mar; 65(3):423-7. PubMed ID: 18093254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
    Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
    Int J Tuberc Lung Dis; 2016 May; 20(5):666-72. PubMed ID: 27084822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic study of isoniazid and pyrazinamide in children: impact of age and nutritional status.
    Dayal R; Singh Y; Agarwal D; Kumar M; Swaminathan S; Ramachandran G; Kumar S; Narayan S; Goyal A; Kumar AKH
    Arch Dis Child; 2018 Dec; 103(12):1150-1154. PubMed ID: 29514812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus.
    Kumar AK; Chandrasekaran V; Kannan T; Murali AL; Lavanya J; Sudha V; Swaminathan S; Ramachandran G
    Eur J Clin Pharmacol; 2017 Jan; 73(1):65-70. PubMed ID: 27651240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Serum Concentrations of Rifampicin and Pyrazinamide Associated with Poor Treatment Outcomes in Children with Tuberculosis Related to HIV Status.
    Ramachandran G; Kumar AK; Kannan T; Bhavani PK; Kumar SR; Gangadevi NP; Banurekha VV; Sudha V; Venkatesh S; Ravichandran N; Kalpana S; Mathevan G; Sanjeeva GN; Agarwal D; Swaminathan S
    Pediatr Infect Dis J; 2016 May; 35(5):530-4. PubMed ID: 26825153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazinamide plasma concentrations in young children with tuberculosis.
    McIlleron H; Willemse M; Schaaf HS; Smith PJ; Donald PR
    Pediatr Infect Dis J; 2011 Mar; 30(3):262-5. PubMed ID: 21416694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs.
    Kumar AKH; Chandrasekaran V; Kumar AK; Kawaskar M; Lavanya J; Swaminathan S; Ramachandran G
    Indian J Med Res; 2017 Apr; 145(4):530-535. PubMed ID: 28862186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of anti-tuberculosis drugs in Venezuelan children younger than 16 years of age: supportive evidence for the implementation of revised WHO dosing recommendations.
    Verhagen LM; López D; Hermans PW; Warris A; de Groot R; García JF; de Waard JH; Aarnoutse RE
    Trop Med Int Health; 2012 Dec; 17(12):1449-56. PubMed ID: 23094704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetic modeling of pyrazinamide in children and adults with tuberculosis.
    Zhu M; Starke JR; Burman WJ; Steiner P; Stambaugh JJ; Ashkin D; Bulpitt AE; Berning SE; Peloquin CA
    Pharmacotherapy; 2002 Jun; 22(6):686-95. PubMed ID: 12066959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of thrice-weekly rifampicin, isoniazid and pyrazinamide in adult tuberculosis patients in India.
    Hemanth Kumar AK; Kannan T; Chandrasekaran V; Sudha V; Vijayakumar A; Ramesh K; Lavanya J; Swaminathan S; Ramachandran G
    Int J Tuberc Lung Dis; 2016 Sep; 20(9):1236-41. PubMed ID: 27510252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrazinamide serum levels in childhood tuberculosis.
    Thee S; Detjen A; Wahn U; Magdorf K
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1099-101. PubMed ID: 18713511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifampicin pharmacokinetics in children under the Revised National Tuberculosis Control Programme, India, 2009.
    Arya A; Roy V; Lomash A; Kapoor S; Khanna A; Rangari G
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):440-5. PubMed ID: 25860000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of first-line antituberculosis drugs in HIV-infected children with tuberculosis treated with intermittent regimens in India.
    Ramachandran G; Kumar AK; Bhavani PK; Kannan T; Kumar SR; Gangadevi NP; Banurekha VV; Sekar L; Ravichandran N; Mathevan G; Sanjeeva GN; Dayal R; Swaminathan S
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1162-7. PubMed ID: 25487804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children.
    Ramachandran G; Hemanth Kumar AK; Bhavani PK; Poorana Gangadevi N; Sekar L; Vijayasekaran D; Banu Rekha VV; Ramesh Kumar S; Ravichandran N; Mathevan G; Swaminathan S
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):800-6. PubMed ID: 23676165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Adequacy of WHO Revised Dosages of the First-Line Antituberculosis Drugs in Children with Tuberculosis Using Population Pharmacokinetic Modeling and Simulations.
    Horita Y; Alsultan A; Kwara A; Antwi S; Enimil A; Ortsin A; Dompreh A; Yang H; Wiesner L; Peloquin CA
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population Pharmacokinetics of Pyrazinamide in Patients with Tuberculosis.
    Alsultan A; Savic R; Dooley KE; Weiner M; Whitworth W; Mac Kenzie WR; Peloquin CA;
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28289033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two doses.
    Ahmad Z; Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2006 May; 27(5):409-16. PubMed ID: 16624533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children.
    Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
    BMC Infect Dis; 2015 Mar; 15():126. PubMed ID: 25887748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.